Ala. Admin. Code r. 540-X-26-.08 - Approval Of The Collaborative Drug Therapy Management Agreement

(1) A physician and pharmacist shall not engage in Collaborative Drug Therapy Management until the Agreement is approved by both the Board of Medical Examiners and the Board of Pharmacy.
(2) Agreements must be submitted to the Board of Medical Examiners and the Board of Pharmacy within ten (10) days after the Agreement is signed by all parties.
(3) Any amendment or addendum to an Agreement must be submitted to the Board of Medical Examiners and Board of Pharmacy within ten (10) days after the amendment is signed by all parties.
(4) No Agreement, nor any amendment or addendum thereto, shall be effective until it is approved by both the Board of Pharmacy and the Board of Medical Examiners.
(5) Each Agreement submitted to the Board of Medical Examiners shall be accompanied by a fee of three hundred dollars ($300). This fee is due and payable concurrently with the submission of an application for a Collaborative Drug Therapy Management Agreement. The fee is not refundable.
(6) Each Agreement submitted to the Board of Pharmacy shall be accompanied by a fee of one hundred dollars ($100). This fee is due and payable concurrently with the submission of an application for a Collaborative Drug Therapy Management Agreement. The fee is not refundable.

Notes

Ala. Admin. Code r. 540-X-26-.08
Adopted by Alabama Administrative Monthly Volume XXXIX, Issue No. 11, August 31, 2021, eff. 10/15/2021.

Author: Alabama Board of Medical Examiners

Statutory Authority: Code of Ala. 1975, § 34-24-53; Act 2019-368 (Code of Ala. 1975, § 34-23-77) .

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.


No prior version found.